Verastem Oncology Reports Fourth Quarter and Full-Year 2019 Financial Results

Go back to Verastem Oncology Reports Fourth Quarter and Full-Year 2019 Financial Results
VERASTEM SHS (NASDAQ: VSTM) Delayed: 7.98 --0 (-0%)
Previous Close $7.98    52 Week High $2.43 
Open $7.98    52 Week Low $1.05 
Day High $7.98    P/E N/A 
Day Low $7.98    EPS $-1.79 
Volume 1,271